Biotech stocks delivered outstanding performance for investors in 2012. After a difficult 2011, biotech stocks took off in January 2012 and never looked back. A quick look at the following chart tells the whole story. As you can see, the Nasdaq... read more »
Investors holding shares of biotech Halozyme Therapeutics (HALO) awoke to excellent news Friday morning. The company announced it had entered into a worldwide collaboration and licensing agreement with Pfizer (PFE). The deal gives Pfizer a global... read more »
2012 has been one of the slowest years ever for IPOs of Chinese stocks on American exchanges. Just three Chinese companies went public in the US this year. That’s way down from the peak set just two years ago. In 2010, a whopping 42... read more »
Barclay’s introduced its first new fund in about a year last week. It’s called the Barclay’s ETN+ Shiller CAPE ETN (CAPE). And it’s designed to outperform the S&P 500 over the long run using Professor Robert Shiller’s Cyclically... read more »
Following August’s lackluster jobs report, the Fed has decided to take additional steps to boost economic growth and curtail unemployment. In case you missed it, Fed Chairman Ben Bernanke made a critical announcement late last week. He said... read more »
Facebook (FB) shares hit the market in May through one of the most highly anticipated IPO’s of all time. But the “can’t miss” stock has so far failed to live up to the hype. Since its debut at $38 per share, FB has shed more than 42%... read more »
Figuring out where to invest in the stock market is a bit trickier than usual of late. The European financial crisis has many worried the European Union could break apart at any minute. And slowing growth in China and the US are sparking concerns... read more »
The Facebook (FB) IPO was hailed as one of the greatest investment opportunities in stock market history. But in the end, it can be summed up with just one word… ANTI-CLIMACTIC! There’s really no other way to describe it. Investors... read more »
The month of May 2012 is set to go down in history. It will forever be remembered as the month Facebook finally went public. That’s right. After months of speculation, the most highly anticipated IPO of all time is nearly ready to go. And... read more »
When was the last time you made ten times your money on a single stock trade? Heck, can you remember the last time you quadrupled or even tripled your money on a stock? Most ordinary investors will have a hard time coming up with an answer to... read more »
LEGAL DISCLAIMER: TopStockAnalysts.com and its parent company, StreetAuthority, LLC, are publishers of financial news and opinions and NOT securities brokers/dealers or investment advisors. You are responsible for your own investment decisions. All information contained in our newsletters or on our web site(s) should be independently verified with the companies mentioned, and readers should always conduct their own research and due diligence and consider obtaining professional advice before making any investment decision. As a condition to accessing our materials and web sites, you agree to our Terms and Conditions of Use, available here, including without limitation all disclaimers of warranties and limitations on liability contained therein. Owners, employees and writers may hold positions in the securities that are discussed in our newsletters or on our web site.
TopStockAnalysts.com
4601 Spicewood Springs Rd. Building 3, Suite 100 Austin, Texas 78759 (512) 501-4002 Copyright © 2006-2013 TopStockAnalysts.com